Skip to main content

Select Drug Profiles

Gavreto Received Regular FDA Approval for Patients With Non–Small Cell Lung Cancer and RET Gene Fusion

Original Research, Practice Management

Employer Disability and Workers’ Compensation Trends for Their Employees With Ophthalmic Conditions in the United States

Richard A. Brook, MS, MBA; Nathan L. Kleinman, PhD; Ian A. Beren, BS

Disparities in Cancer Care, Urothelial Cancer, Oncology

Addressing Health Equity in Bladder Cancer Care

William King

Lonsurf Received a New Indication, in Combination With Bevacizumab, for Previously Treated Metastatic Colorectal Cancer

Jemperli Plus Chemotherapy Now FDA Approved for Front-Line Treatment of dMMR or MSI-H Endometrial Cancer

Tornado Sweeps Through Pfizer’s Storage and Manufacturing Facility

Vanflyta Now Approved for Newly Diagnosed FLT3-ITD–Positive AML

In the News, Technology

Acceptance of Artificial Intelligence in Healthcare Is Making Inroads

Original Research

Cost-Savings Using Patients’ Own Medication Supply of Letermovir for Allogeneic Hematopoietic Stem-Cell Transplant Recipients During Hospitalization

Harrison S. Yoon, PharmD; Mallory Crain, PharmD, BCOP; Marissa Olson, PharmD, BCOP; Anupam Pande, MD, MPH; Jeff O. Klaus, PharmD, BCPS

Practice Management

Survey Shows Inflation Affecting Majority of Consumer Healthcare Decisions

Page 10 of 244
Results 91 - 100 of 2438